Smoking Cessation

A strong medication plus behavioural support, rather than either on its own — and definitely rather than willpower alone, which is the most attempted and least effective method. In the current Cochrane network meta-analysis of 319 trials, the top tier was nicotine e-cigarettes (OR 2.37), varenicline (OR 2.33) and cytisine (OR 2.21), all roughly doubling quit rates versus control. Combination nicotine replacement — a patch for background cover plus a fast-acting form such as gum, lozenge or spray for cravings — was close behind (OR 1.93). Notably weaker were a nicotine patch alone (OR 1.37), a fast-acting form alone (OR 1.41) and bupropion (OR 1.43). So the single most useful thing to know is that using one patch on its own is roughly half as helpful as the best options, and many people who conclude 'NRT doesn't work for me' have only ever tried the weakest version of it. Which option is right for you depends on your medical history and what you can access — that part is a conversation with a clinician or pharmacist.

No — and this misconception costs lives, because it pushes people back to cigarettes. Nicotine is what makes smoking addictive, but it is not what makes smoking deadly. The cancers, lung disease and heart attacks are caused by what burning tobacco produces: tar, carbon monoxide and a long list of carcinogens. Nicotine replacement gives you the nicotine without the combustion, which is the entire idea. That is not the same as saying nicotine is harmless — it is strongly addictive, it has cardiovascular effects, and its use in pregnancy needs discussion — but the comparison that matters for a smoker is with the cigarette, not with nothing. If you find yourself using nicotine replacement for longer than the box suggests, that is a far better place to be than smoking, and worth discussing rather than panicking about.

It is a legitimate option with real evidence, and it comes with a real caveat. The current Cochrane review found high-certainty evidence that nicotine e-cigarettes help more people quit than nicotine replacement therapy does (RR 1.59), with adverse-event rates that were probably similar; the landmark trial found 18.0% still abstinent at a year with e-cigarettes versus 9.9% with NRT. Because there is no combustion, vaping is far less harmful than smoking — which is the relevant comparison if you currently smoke. The caveats are honest ones: nobody has followed vapers for the thirty-plus years it took to prove what cigarettes do, so the long-term picture is unknown rather than clean; and in that same trial, 80% of the people who quit smoking using e-cigarettes were still vaping a year later, compared with 9% of the NRT group. Vaping is a good way to stop smoking and a poor way to stop nicotine. If you smoke, that trade is usually strongly worth making. If you don't smoke, there is no version of this evidence that recommends starting.

The large gains are real, and BioSignal is going to be careful about the parts that get overstated. What is solidly established is the mortality picture: continuing smokers die about ten years earlier than never-smokers on average, and quitting at around 30, 40, 50 or 60 returns roughly 10, 9, 6 or 3 of those years — with cessation before 40 avoiding about 90% of the excess risk of death. That is a population average, not a promise to any individual, and it is a reduction in risk rather than an erasure of it: some risk, particularly of lung cancer, stays above never-smoker levels for a long time. You will also meet detailed hour-by-hour and day-by-day 'recovery timelines' in a lot of quit-smoking material. BioSignal does not publish those, because the precision they imply is not backed by the evidence they cite. What can be said honestly is that withdrawal symptoms — irritability, poor concentration, low mood, restlessness, strong cravings — are worst in the first days to weeks and then ease, and that the mortality benefit accrues over years and is larger the earlier you start.

Yes — and the premise of the question is worth challenging. Most people who stop smoking permanently do it after several attempts; that is the normal shape of quitting, not a sign that you are unusually bad at it. Previous attempts do not use up your chances. The more useful question is not whether to try again but what to change: if the last attempt was unaided, the evidence says almost anything structured will do better; if it was a single patch, combination NRT or varenicline is roughly twice as strong; if you have never had behavioural support alongside medication, that combination beats either alone. A relapse is information about the method, not a verdict on you. And a slip — one cigarette — is only a relapse if it is treated as permission to resume, which is why it is worth deciding in advance that it is not.

That concern was taken seriously, tested properly, and largely not confirmed. Varenicline once carried a boxed warning for neuropsychiatric events. EAGLES, a large double-blind randomised trial that deliberately included smokers with psychiatric disorders, did not find a significant increase in neuropsychiatric adverse events from varenicline or bupropion compared with nicotine patch or placebo — and found varenicline more effective than all three comparators. The FDA removed the boxed warning afterwards. Worth knowing alongside that: the trial was funded by the manufacturers, Pfizer and GlaxoSmithKline. Varenicline does have common side effects — nausea especially, and vivid or unusual dreams — and if you feel psychiatrically worse while taking it, that is a reason to contact your prescriber rather than to push on. Also relevant: untreated nicotine withdrawal itself causes low mood and irritability, which is part of why isolating the drug's effect needed a trial this size.

Stopping is one of the most valuable things you can do for the pregnancy, and this is the area where BioSignal will be most explicit that a page is not enough. Behavioural support is the mainstay and has the best evidence in pregnancy. The medication picture is genuinely weaker here than elsewhere: the Cochrane review of pharmacological cessation in pregnancy found the evidence for nicotine replacement less certain than in the general population, and varenicline and bupropion are not established in pregnancy. That does not mean the answer is to keep smoking — continued smoking has clear, well-documented harms for the pregnancy — it means the choice between options genuinely needs a clinician who knows your history, and it needs one soon rather than after the first trimester. Please raise it with your midwife or doctor; this is one of the few situations where the treatment decision is unusually individual and the value of getting help early is unusually high.